Moolec Science (MLEC) Profit After Tax (2022 - 2024)
Moolec Science's (MLEC) quarterly Profit After Tax came in at $2.4 million in Q4 2024, up 36.1% year-on-year from $1.8 million in Q1 2024, and up 226.72% quarter-over-quarter from -$1.9 million in Q3 2024.
Moolec Science (MLEC) Profit After Tax (2022 - 2024) Analysis & Trends
Moolec Science has disclosed Profit After Tax across 3 years of filings, most recently posting $2.4 million for Q4 2024.
- Profit After Tax for Q4 2024 came in at $2.4 million, up 36.1% year-over-year; the trailing twelve-month figure through Dec 2024 was -$30.0 million (down 927.82% YoY), and the FY2024 annual result was -$29.1 million, down 154.71% from the prior year.
- Profit After Tax came in at $2.4 million for Q4 2024 at Moolec Science, up from -$1.9 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $48.0 million in Q4 2022 to a low of -$29.1 million in Q2 2024.
- The 3-year median for Profit After Tax is -$1.3 million (2022), against an average of -$444923.9.
- Across the five-year window, Profit After Tax jumped 86.25% in 2023 and tumbled 957.53% in 2024, its largest moves.
- Moolec Science's Profit After Tax stood at $48.0 million in 2022, then tumbled by 96.28% to $1.8 million in 2023, then surged by 36.1% to $2.4 million in 2024.
- The last three Profit After Tax figures came in at $2.4 million (Q4 2024), -$1.9 million (Q3 2024), and -$29.1 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -14.46 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | -3.63 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -56.74 Mn |
| 10 | Moolec Science | 6.98 Bn | 6.98 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 2.43 Mn |
| Sep 30, 2024 | -1.92 Mn |
| Jun 30, 2024 | -29.06 Mn |
| Mar 31, 2024 | -1.40 Mn |
| Dec 31, 2023 | 1.78 Mn |
| Sep 30, 2023 | -1.59 Mn |
| Jun 30, 2023 | -2.75 Mn |
| Mar 31, 2023 | -358,578.00 |
| Dec 31, 2022 | 47.96 Mn |
| Sep 30, 2022 | 721,426.00 |
| Jun 30, 2022 | -19.99 Mn |
| Mar 31, 2022 | -1.17 Mn |